Biotherapeutics - news, views, reports and blogs

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Latest Biotherapeutics News - RSS feed - Twitter account - @Biotherapeutic1 -...

iBioLaunch

The iBioLaunch™ platform is a  proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins.  The plants are easily and...

BioPortfolio Twitter Accounts

BioPortfolio has created a number of Twitter accounts to help you keep upto date on the latest news, research papers, reports and clinical trials on a selected range of important and popular topics....

Helicos Files Chapter 11

GEN | Next-gen sequencing company Helicos filed for Chapter 11 protection yesterday. In the filing, Helicos listed $15.478 million in liabilities and only $3.503 million in assets.

News Summary: K-V Pharma files Chapter 11

CHAPTER 11: K-V Pharmaceutical Co. filed for Chapter 11 bankruptcy protection Saturday, saying weak sales of its preterm birth drug Makena and regulatory sanctions are hurting its business.REORGANIZIN...

Battered Helicos Files for Chapter 11

Valence Technology Files Voluntary Chapter 11 Business Reorganization

Flow of Goods and Services to Customers to Continue Globally in Ordinary Course Non‐U.S. Subsidiaries Are Not Included in U.S. Filing and Are Not Subject to Court Supervision Company Negoti...

MicroPhage files for bankruptcy protection

Denver Business Journal - MicroPhage Inc. (Longmont) maker of the first U.S. blood test identifying antibiotic-resistant staph infections, has filed for Chapter 11 bankruptcy. www.bizjournals.com...

Skinny Nutritional Corp. Files a Voluntary Chapter 11 and Begins Its Restructuring and Financing Plan to Restore Growth and Value to the Company

BRYN MAWR, Pa., May 8, 2013 (GLOBE NEWSWIRE) -- Skinny Nutritional Corp. (Pink Sheets:SKNY) announced today it filed a voluntary Chapter 11 petition in the United States Bankruptcy Court for the East...

HMX Acquisition Corp. Files for Chapter 11, Salus Capital to Provide DIP Facility and Authentic Brands Group Selected as Stalking Horse Bidder

NEW YORK, Oct. 19, 2012 (GLOBE NEWSWIRE) -- HMX Acquisition Corp. today announced that it has filed voluntary Chapter 11 petitions. In conjunction with the filing, the Company's existing lender has r...

Smith & Nephew acquires Healthpoint Biotherapeutics for $782 million

Smith & Nephew has signed an agreement to acquire substantially all of the assets of Healthpoint Biotherapeutics for $782 million in cash. Healthpoint Biotherapeutics has been focused on biopharma...

Coupling of Aggregation and Immunogenicity in Biotherapeutics: T- and B-Cell Immune Epitopes May Contain Aggregation-Prone Regions.

Biotherapeutics, including recombinant or plasma-derived human proteins and antibody-based molecules, have emerged as an important class of pharmaceuticals. Aggregation and immunogenicity are among th...

Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration.

The subcutaneous (SC) route is of growing interest for the administration of biotherapeutics. Key products on the biotherapeutic market such as insulins, but also several immunoglobulins or Fc-fusion...

Electrochemical corrosion assessment of RaCe and Mtwo rotary nickle-titanium instruments after clinical use and sterilization.

Aim: The aim of the present study was to electrochemically evaluate corrosion resistance of RaCe and Mtwo files after repeated sterilization and preparation procedures. Study Design: A total of 450 ro...

Subcutaneous administration of biotherapeutics: Current experience in animal models.

In recent years, many peptide- and protein-based biotherapeutics have been approved for subcutaneous (SC) delivery. The mechanisms and factors affecting the uptake and distribution of such large molec...

Protein Particulate Detection Issues in Biotherapeutics Development-Current Status.

Formation of aggregates and particulates in biopharmaceutical formulation continues to be one of the major quality concerns in biotherapeutics development. The presence of large quantities of aggregat...